Jillian Angelina Dolan, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4 Corporate Dr Ste 286, Shelton, CT 06484 Phone: 203-929-9000 |
Miss Dorothy Gutwein, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4 Corporate Dr, Suite #484, Shelton, CT 06484 Phone: 203-944-9898 Fax: 203-944-9899 |
Dr. Scott Alan Vander Vennet, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Ivy Brook Rd Ste 125, Shelton, CT 06484 Phone: 203-954-0080 Fax: 203-954-0084 |
Xiaolan Fei, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Ivy Brook Rd Ste 125, Shelton, CT 06484 Phone: 203-516-5303 Fax: 203-732-8136 |
Rachel Adelia Lim Leonardi, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr, Suite 484, Shelton, CT 06484 Phone: 203-944-9898 Fax: 203-944-9899 |
Mr. Michael O'reilly, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr, Suite # 484, Shelton, CT 06484 Phone: 203-944-9898 Fax: 203-944-9899 |
News Archive
Researchers at the University of Surrey, in collaboration with the Universities of Reading and Cologne, and the Royal Berkshire Hospital, have discovered that it is possible to stop the activation of a group of proteins (NADPH Oxidase) known to cause most of the diseases of ageing.
Just days after the head of Ofsted, Christine Gilbert, promised an overhaul of child protection inspection services in the wake of the death of Baby P, a new study claims that the IT-based procedures used by staff working at the 'front door' of local authority children's services could be putting the very children which they are designed to help at increased risk.
A Journal of Addiction Medicine (JAM) study was cited in a recent Center for Substance Abuse Research (CESAR) series highlighting an emerging problem in addiction therapy: the diversion and misuse of the medication buprenorphine.
Sinovac Biotech Ltd., a leading provider of vaccines in China, announced today that Fengcai Zhu, Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, presented data regarding Sinovac's proprietary enterovirus 71 ("EV71") vaccine against hand, foot and mouth disease at the 13th Annual World Vaccine Congress & Expo, taking place from April 16-18, 2013, in Washington D.C.
Biomerix Corporation, a medical technologies company developing and manufacturing innovative regenerative medicine biomaterials, and Synthecon, a leading biotechnology company specializing in the design and manufacturing of rotating cell culture systems, today announced a strategic distribution agreement for three-dimensional cell culture scaffolds developed using Biomerix Corporation's unique biomaterial technology.
› Verified 9 days ago